Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Stratification for Subclinical Leaflet Thrombosis Post TAVI Using Thromboelastography

NCT03649594 is registered in ClinicalTrials.gov with Torben Pottgiesser as lead sponsor.

NCT NCT03649594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03649594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Stratification for Subclinical Leaflet Thrombosis Post TAVI Using Thromboelastography
Lead sponsor
Torben Pottgiesser
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2020
Completion date
April 30, 2023
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis, cardiovascular diseases, platelet function tests, predictive value of tests, thrombelastography, thrombosis, transcatheter aortic valve replacement